| Schedule of Segment Information |
Selected financial information for the Company’s operating
segments is as follows:
| |
|
Year Ended December 31, |
|
| |
|
2019 |
|
|
2018 |
|
| Net revenues - External |
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
15,927,983 |
|
|
$ |
14,417,676 |
|
| Clinical Laboratory Operations |
|
|
58,941 |
|
|
|
131,014 |
|
| |
|
$ |
15,986,924 |
|
|
$ |
14,548,690 |
|
| Loss from operations |
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
(11,060,401 |
) |
|
$ |
(6,434,538 |
) |
| Clinical Laborabory Operations |
|
|
(1,061,145 |
) |
|
|
(2,247,499 |
) |
| Corporate |
|
|
(4,209,378 |
) |
|
|
(4,542,583 |
) |
| |
|
$ |
(16,330,924 |
) |
|
$ |
(13,224,620 |
) |
| Depreciation and amortization |
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
715,286 |
|
|
$ |
498,352 |
|
| Clinical Laboratory Operations |
|
|
79,232 |
|
|
|
764,445 |
|
| Corporate |
|
|
683 |
|
|
|
1,047 |
|
| |
|
$ |
795,201 |
|
|
$ |
1,263,844 |
|
| Capital expenditures |
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
127 |
|
|
$ |
213,105 |
|
| Clinical Laboratory Operations |
|
|
- |
|
|
|
- |
|
| |
|
$ |
127 |
|
|
$ |
213,105 |
|
| |
|
Year Ended December 31, |
|
| |
|
2019 |
|
|
2018 |
|
| Total assets |
|
|
|
|
|
|
|
|
| Hospital Operations |
|
$ |
14,275,256 |
|
|
$ |
13,568,933 |
|
| Clinical Laboratory Operations |
|
|
330,381 |
|
|
|
271,426 |
|
| Corporate |
|
|
2,305,380 |
|
|
|
2,707,416 |
|
| Assets of AMSG and HTS classified as held for sale |
|
|
514,772 |
|
|
|
152,171 |
|
| Eliminations |
|
|
(2,718,130 |
) |
|
|
(2,500,646 |
) |
| |
|
$ |
14,707,659 |
|
|
$ |
14,199,300 |
|
|